We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+5.65%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.01B
AUM Growth
+$205M
(+25%)
Cap. Flow
+$234M
Cap. Flow
% of AUM
23.15%
Top 10 Holdings %
Top 10 Hldgs %
4.25%
Holding
2,085
New
689
Increased
399
Reduced
339
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
National Vision
EYE
|
+$5.45M |
| 2 |
Altimmune
ALT
|
+$4.45M |
| 3 |
FRC
First Republic Bank
FRC
|
+$4.06M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.99M |
| 5 |
Hilton Worldwide
HLT
|
+$3.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PG&E
PCG
|
+$7.74M |
| 2 |
Dropbox
DBX
|
+$3.02M |
| 3 |
Progressive
PGR
|
+$2.77M |
| 4 |
Southwest Airlines
LUV
|
+$2.69M |
| 5 |
Transocean
RIG
|
+$2.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.8% |
| 2 | Consumer Discretionary | 14.87% |
| 3 | Healthcare | 14.13% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Madrigal Pharmaceuticals
MDGL
$11.8B
| $785K | 0.08% |
+3,240
| New | +$883K |
|
452
Century Aluminum
CENX
$5.07B
| $784K | 0.08% |
+78,381
| New | +$812K |
|
|
VERV
453
DELISTED
Verve Therapeutics
VERV
| $783K | 0.08% |
+54,284
| New | +$1.06M |
|
454
Keros Therapeutics
KROS
$221M
| $782K | 0.08% |
18,324
+10,151
| +124% | +$513K |
|
455
Microvision
MVIS
$79M
| $781K | 0.08% |
19,500
-7,073
| -27% | -$268K |
|
456
John Wiley & Sons Class A
WLY
$2.66B
| $780K | 0.08% |
+20,115
| New | +$857K |
|
457
Coca-Cola Europacific Partners
CCEP
$47.9B
| $779K | 0.08% |
13,159
-454
| -3% | -$25.4K |
|
458
Dorman Products
DORM
$4.18B
| $778K | 0.08% |
+9,020
| New | +$803K |
|
|
SCS
459
DELISTED
Steelcase
SCS
| $778K | 0.08% |
92,411
+37,407
| +68% | +$287K |
|
|
ARR
460
Armour Residential REIT
ARR
$2.36B
| $777K | 0.08% |
29,599
+27,386
| +1,238% | +$774K |
|
461
MP Materials
MP
$9.1B
| $777K | 0.08% |
27,578
+7,307
| +36% | +$221K |
|
462
Asana
ASAN
$2.13B
| $775K | 0.08% |
36,694
+21,184
| +137% | +$351K |
|
463
Bank of N.T. Butterfield & Son
NTB
$2.45B
| $775K | 0.08% |
28,712
+18,312
| +176% | +$585K |
|
464
Universal Insurance Holdings
UVE
$1.23B
| $772K | 0.08% |
+42,393
| New | +$627K |
|
|
CWAN
465
DELISTED
Clearwater Analytics
CWAN
| $767K | 0.08% |
+48,086
| New | +$841K |
|
466
Spok Holdings
SPOK
$241M
| $767K | 0.08% |
75,687
+22,626
| +43% | +$207K |
|
|
SCPL
467
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $766K | 0.08% |
+45,178
| New | +$741K |
|
468
CVS Health
CVS
$122B
| $764K | 0.08% |
+10,281
| New | +$862K |
|
|
DMC
469
Del Monte Corp
DMC
$1.45B
| $764K | 0.08% |
+25,363
| New | +$737K |
|
470
Hydrofarm Holdings
HYFM
$7.62M
| $764K | 0.08% |
44,167
+14,641
| +50% | +$259K |
|
471
Upland Software
UPLD
$15.4M
| $764K | 0.08% |
17,767
+15,413
| +655% | +$1.07M |
|
472
American Tower
AMT
$80.4B
| $763K | 0.08% |
+3,733
| New | +$783K |
|
|
PLYA
473
DELISTED
Playa Hotels & Resorts
PLYA
| $760K | 0.08% |
79,142
-17,909
| -18% | -$143K |
|
474
American Vanguard Corp
AVD
$68.9M
| $759K | 0.08% |
34,692
-8,334
| -19% | -$180K |
|
475
Genesis Energy
GEL
$1.84B
| $759K | 0.08% |
67,422
+6,273
| +10% | +$70.6K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q1 2023 Portfolio in Review
As of Q1 2023, GSA Capital Partners held 2,085 positions worth $1.01B, up 25% from $806M the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.
GSA Capital Partners deployed $234M of net new capital in Q1 2023, opening 689 new positions and adding to 399 existing holdings. Its largest new stake was National Vision: 167,499 shares worth $3.16M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Transocean, an estimated $2.59M trimmed.
- GSA Capital Partners's largest Q1 2023 buy was National Vision: 167,499 shares worth $3.16M.
- GSA Capital Partners added most to Altimmune in Q1 2023, an estimated $4.45M increase.
- GSA Capital Partners's biggest Q1 2023 reduction was Transocean, cutting an estimated $2.59M.
- GSA Capital Partners fully exited PG&E in Q1 2023, selling an estimated $7.74M.
- GSA Capital Partners's ten largest holdings make up 4.2% of its $1.01B portfolio in Q1 2023.
- GSA Capital Partners opened 689 new positions and closed 654 in Q1 2023.
- GSA Capital Partners's portfolio value rose 25% quarter-over-quarter to $1.01B.
Based on GSA Capital Partners's 13F filing for Q1 2023, filed 12 May 2023.